Bartosz Klebowski
Overview
Explore the profile of Bartosz Klebowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Depciuch J, Sieminska I, Jakubczyk P, Klebowski B, Ptak K, Szymonska I, et al.
Sci Rep
. 2025 Feb;
15(1):4669.
PMID: 39920293
Pediatric Inflammatory Multisystem Syndrome (PIMS-TS), associated with SARS-CoV-2 infection, is a severe complication after COVID-19 in children. It is caused by the immune reaction to SARS-CoV-2, and usually appears three...
2.
Tolpa B, Paja W, Jakubczyk P, Lach K, Trojnar E, Gala-Bladzinska A, et al.
Anal Biochem
. 2024 Dec;
699():115754.
PMID: 39734008
Brain tumors are among the most dangerous, due to their location in the organ that governs all life processes. Moreover, the high differentiation of these poses a challenge in diagnostics....
3.
Klebowski B, Kosinska K, Bukowska A, Zielinski P, Parlinska-Wojtan M, Depciuch J
Biochim Biophys Acta Gen Subj
. 2024 Dec;
1869(2):130743.
PMID: 39681276
Titanium oxide nanoparticles (TiO NPs) are currently used as ingredients in medicines and sunscreens. Unfortunately, recent information about TiO NPs indicates their undesirable biological effect on colon cells. Therefore, the...
4.
Mitura P, Paja W, Klebowski B, Plaza P, Bar K, Mlynarczyk G, et al.
J Biophotonics
. 2024 Nov;
18(1):e202400278.
PMID: 39572857
Prostate-specific antigen (PSA) is the most commonly used marker of prostate cancer. However, nearly 25% of men with elevated PSA levels do not have cancer and nearly 20% of patients...
5.
Mitura P, Paja W, Klebowski B, Plaza P, Kuliniec I, Bar K, et al.
Spectrochim Acta A Mol Biomol Spectrosc
. 2024 Nov;
327:125305.
PMID: 39490177
Prostate cancer represents the second most prevalent form of cancer in males globally. In the diagnosis of prostate cancer, the most commonly utilised biomarker is prostate-specific antigen (PSA). It is...
6.
Kluz-Barlowska M, Kluz T, Paja W, Sarzynski J, Barnas E, Laczynska-Madera M, et al.
Sci Rep
. 2024 Oct;
14(1):24923.
PMID: 39438723
Patients with high-grade ovarian cancer have a poor prognosis, thus effective treatment remains an unmet medical issue of high importance. Moreover, finding the reason for resistance to cisplatin is a...
7.
Kesik J, Paja W, Terlecki P, Ilzecki M, Klebowski B, Depciuch J
Spectrochim Acta A Mol Biomol Spectrosc
. 2024 Sep;
326:125198.
PMID: 39340949
Atherosclerosis carotid stenosis (ACS) is one of the main causes of stroke. Unfortunately, the highest number of people go to the doctor with an advanced disease or as a result...
8.
Depciuch J, Jakubczyk P, Jakubczyk D, Klebowski B, Miszczyk J, Parlinska-Wojtan M
Small
. 2024 May;
20(37):e2400778.
PMID: 38747048
Herein, it is demonstrated that the toxic effect of gold nanoparticles (Au NPs) on three different cancer cell lines (U-118 and LN-299 glioblastoma and HCT-116 colon) depends on their absorption...
9.
Klebowski B, Stec M, Depciuch J, Panek A, Krzempek D, Komenda W, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497386
Nano-sized radiosensitizers can be used to increase the effectiveness of radiation-based anticancer therapies. In this study, bimetallic, ~30 nm palladium-platinum nanoparticles (PdPt NPs) with different nanostructures (random nano-alloy NPs and...
10.
Klebowski B, Stec M, Depciuch J, Galuszka A, Pajor-Swierzy A, Baran J, et al.
Pharmaceutics
. 2021 Oct;
13(10).
PMID: 34684019
Noble metal nanoparticles, such as gold (Au NPs), platinum (Pt NPs), or palladium (Pd NPs), due to their highly developed surface, stability, and radiosensitizing properties, can be applied to support...